Senti Biosciences Holdings, Inc.
SNTI
$0.30
-$0.02-5.32%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 17.00K | 16.00K | 22.00K | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.00K | 16.00K | 22.00K | -- | -- |
| Cost of Revenue | 7.77M | 5.28M | 7.76M | 10.52M | 10.03M |
| Gross Profit | -7.75M | -5.27M | -7.74M | -10.52M | -10.03M |
| SG&A Expenses | 5.74M | 6.15M | 423.00K | 8.00M | 5.18M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.51M | 11.43M | 8.18M | 18.52M | 15.21M |
| Operating Income | -13.49M | -11.42M | -8.16M | -18.52M | -15.21M |
| Income Before Tax | -12.75M | -4.22M | -14.47M | -18.13M | -14.73M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.75M | -4.22M | -14.47M | -18.13M | -14.73M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.75M | -4.22M | -14.47M | -18.13M | -14.73M |
| EBIT | -13.49M | -11.42M | -8.16M | -18.52M | -15.21M |
| EBITDA | -12.83M | -10.73M | -7.27M | -17.61M | -14.30M |
| EPS Basic | -0.41 | -0.14 | -0.53 | -0.69 | -0.56 |
| Normalized Basic EPS | -0.26 | -0.22 | -0.21 | -0.43 | -0.35 |
| EPS Diluted | -0.41 | -0.14 | -0.53 | -0.69 | -0.56 |
| Normalized Diluted EPS | -0.26 | -0.22 | -0.21 | -0.43 | -0.35 |
| Average Basic Shares Outstanding | 31.14M | 30.97M | 27.38M | 26.23M | 26.08M |
| Average Diluted Shares Outstanding | 31.14M | 30.97M | 27.38M | 26.23M | 26.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |